What is Johnson & Johnson's opsumit/opsynvi(2) — percent change (as a percent)?

Johnson & Johnson (JNJ) reported opsumit/opsynvi(2) — percent change (as a percent) of -1.3% in Q3 2025.

What does opsumit/opsynvi(2) — percent change (as a percent) mean?

The percentage growth or decline in revenue for a specific product line compared to the previous period.

OPSUMIT/OPSYNVI(2) — Percent Change (as a percent)

Products & Services · Percent Change (as a percent)

Johnson & Johnson OPSUMIT/OPSYNVI(2) — Percent Change (as a percent) decreased by 107.0% to -1.3% in Q3 2025 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityModerate

First reportedQ1 2025

Last reportedQ3 2025

How to read this metric

A positive percentage indicates accelerating market penetration or pricing power, whereas a negative percentage suggests market saturation or loss of exclusivity.

Detailed definition

This metric measures the period-over-period growth rate of revenue for a specific pharmaceutical product line. It isolat...

Peer comparison

Comparable to organic segment growth rates or product-specific revenue growth metrics provided by peer pharmaceutical firms.

Metric ID: jnj_segment_opsumit_opsynvi_percent_change_as_a_percent

Historical Data

3 periods

	Q1 '25	Q2 '25	Q3 '25
Value	-4.4%	18.7%	-1.3%
QoQ Change	—	+525.0%	-107.0%

Range-4.4% – 18.7%

Similar Metrics at Other Companies

Eli LillyLLY View metric

Frequently Asked Questions

What is Johnson & Johnson's opsumit/opsynvi(2) — percent change (as a percent)?: Johnson & Johnson (JNJ) reported opsumit/opsynvi(2) — percent change (as a percent) of -1.3% in Q3 2025.
What does opsumit/opsynvi(2) — percent change (as a percent) mean?: The percentage growth or decline in revenue for a specific product line compared to the previous period.